Concepedia

Yining Ye

YY

Statistics

Publications

20

Citations

3.5K

H-Index

17

Active since

2005

Affiliations

Amgen (United States)(Current)

The University of Texas MD Anderson Cancer Center

University of North Carolina at Chapel Hill

Northern California Melanoma Center

University of Utah

Yining Ye is an author at Amgen (United States) specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2005–2024

20

Publications

20

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio et al. · Journal of Clinical Oncology · 2015 · 2.5K citations · Full text

Semiparametric Analysis of Correlated Recurrent and Terminal Events

Yining Ye, John D. Kalbfleisch, Douglas E. Schaubel · Biometrics · 2007 · 142 citations · Full text

, , +15

Predictors of Habitual Snoring and Obstructive Sleep Apnea Risk in Patients With Asthma

Mihaela Teodorescu, Flavia B. Consens, William F. Bria et al. · CHEST Journal · 2008 · 122 citations

, , +10

OPTiM: A randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma.

Robert Hans Ingemar Andtbacka, Frances A. Collichio, Thomas Amatruda et al. · Journal of Clinical Oncology · 2013 · 117 citations

, , +19

OPTiM: A randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma.

Robert Hans Ingemar Andtbacka, Frances A. Collichio, Thomas Amatruda et al. · Journal of Clinical Oncology · 2013 · 84 citations

, , +21

1–5 of 20